CIK 0001386570
- Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262940963
- Phone
- +1 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.41 ($7,050)
- 4 Open-market buy Director bought 3,467,778 shares
- 4 Exercise or conversion Chief Financial Officer acquired 22,436 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 7,000 shares at $1.69 ($11,830)
- 4 Open-market buy Chief Executive Officer bought 7,000 shares at $1.42 ($9,940)
- 4 Open-market buy Director bought 7,000 shares at $1.46 ($10,220)
- 4 Derivatives Options or other derivatives
Page 3 of 20 · 384 filings